마우스 모델 기술 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Mice Model Technologies Market size is expected to reach USD 5.65 Billion in 2034 from USD 2.85 Billion (2025) growing at a CAGR of 7.91% during 2026-2034.

The Global Mice Model Technologies Market is expanding steadily due to increasing preclinical research activities in pharmaceuticals and biotechnology. Rising demand for disease-specific and humanized mouse models has strengthened research capabilities in oncology, immunology, and genetic disorders. Growing investments in drug discovery and translational research are further accelerating market development. Academic research institutions and contract research organizations are key contributors to sustained demand.

Major growth drivers include advancements in genome-editing technologies, particularly CRISPR-based modifications, which enable rapid and precise model development. Increased outsourcing of preclinical testing services and stricter regulatory requirements for safety data are also fueling adoption. The rise of immuno-oncology research and personalized medicine approaches further increases demand for advanced and genetically engineered models.

Looking ahead, the market is expected to benefit from improved humanized mouse platforms and integrated data analytics services. Ethical considerations and alternative testing technologies may influence growth dynamics, but whole-organism research will remain critical. Companies offering faster model generation, specialized strains, and comprehensive research services are likely to strengthen their market position.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

• CRISPR Knockout
• CRISPR Knockin
• Random Insertions
• Large, Targeted Insertions
• ES Cell Modification (Homologous Recombination)
• Others

By End-User

• Pharmaceutical Companies
• Biotechnology Companies
• Academic and Research Facilities
• Contract Research and Manufacturing Organizations

COMPANIES PROFILED

• Biocytogen, Charles River Laboratories, Cyagen Biosciences, Gempharmatech, genOway, ingenious targeting laboratory, Merck KGaA, Ozgene Pty Ltd, Taconic Biosciences Inc, PolyGene AG, The Jackson Laboratory
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL MICE MODEL TECHNOLOGIES MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Technology
• 4.2. CRISPR Knockout Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. CRISPR Knockin Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Random Insertions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Large, Targeted Insertions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. ES Cell Modification (Homologous Recombination) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL MICE MODEL TECHNOLOGIES MARKET: BY END-USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End-user
• 5.2. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Academic and Research Facilities Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Contract Research and Manufacturing Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL MICE MODEL TECHNOLOGIES MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Technology
  • 6.2.2 By End-user
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Technology
  • 6.3.2 By End-user
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Technology
  • 6.4.2 By End-user
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Technology
  • 6.5.2 By End-user
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Technology
  • 6.6.2 By End-user
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL MICE MODEL TECHNOLOGIES INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Biocytogen
  • 8.2.2 Charles River Laboratories
  • 8.2.3 Cyagen Biosciences
  • 8.2.4 Gempharmatech
  • 8.2.5 GenOway
  • 8.2.6 Ingenious Targeting Laboratory
  • 8.2.7 Merck KGaA
  • 8.2.8 Ozgene Pty Ltd
  • 8.2.9 Taconic Biosciences Inc
  • 8.2.10 PolyGene AG
  • 8.2.11 The Jackson Laboratory